Prescription drug pricing.

CA AB1460 aims to regulate the pricing of prescription drugs in California. The bill seeks to add new provisions to the Health and Safety Code that would enhance transparency in drug pricing and ensure that consumers are not overcharged for medications. This legislation is part of a broader effort to make healthcare more affordable for residents.

Supporters of AB1460 argue that this bill is a crucial step towards making prescription drugs more affordable and accessible for all Californians. They believe that increased transparency in drug pricing will empower consumers and help reduce the financial burden of healthcare costs. Advocates see this legislation as a necessary measure to hold pharmaceutical companies accountable.

Critics of AB1460 contend that the bill could lead to unintended consequences, such as increased costs for pharmaceutical companies that may be passed on to consumers. They argue that the legislation may stifle innovation in drug development and could result in fewer new medications being brought to market. Opponents also express concerns about the regulatory burden it may impose on the healthcare industry.